Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Scandinavian Journal of Work, Environment & Health|January 7, 2005
Chronic inflammation induced by organic dust and related metabolic cardiovascular disease risk factorsYvon Cormier, Evelyne Israël-AssayagAmerican Journal of Industrial Medicine|March 22, 2006
Adiposity affects human response to inhaled organic dustYvon Cormier, Evelyne Israël-AssayagCurrent Opinion in Allergy and Clinical Immunology|March 17, 2004
Pathogenesis of hypersensitivity pneumonitisMelissa Girard, Evelyne Israël-Assayag, Yvon CormierPlos One|March 24, 2015
ASM-024, a piperazinium compound, promotes the in vitro relaxation of β2-adrenoreceptor desensitized tracheasEvelyne Israël-Assayag, Marie-Josée Beaulieu, Yvon CormierAmerican Journal of Respiratory and Critical Care Medicine|January 1, 2004
Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitroMarie-Renée Blanchet, Evelyne Israël-Assayag, Yvon CormierPlos One|January 28, 2014
Bronchodilatory and anti-inflammatory effects of ASM-024, a nicotinic receptor ligand, developed for the treatment of asthmaEvelyne Israël Assayag, Marie-Josée Beaulieu, Yvon CormierJournal of Occupational and Environmental Hygiene|July 26, 2006
Sensitization to airborne molds and its health effects in peat moss processing plant workersAnne Mériaux, Yvon Cormier, Pascal Pageau, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|June 20, 2006
Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activationMarie-Renée Blanchet, Evelyne Israël-Assayag, Pascal Daleau, et al.Journal of Leukocyte Biology|February 10, 2007
Modulation of eosinophil activation in vitro by a nicotinic receptor agonistMarie-Renée Blanchet, Anick Langlois, Evelyne Israël-Assayag, et al.Pageof 1